February 13, 2018
BD with pre-market approval from FDA for BD Onclarity HPV assay
BD has received pre-market approval from the U.S. Food and Drug Administration for the BD Onclarity HPV assay, the company…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
February 12, 2018
Actinium seeks chance to maximize value for partners and collaborators, applies Acute Myeloid Leukemia treatment for investigation
Actinium Pharmaceuticals has applied an Investigational New Drug for Actimab-A combined with CLAG-M, for Acute Myeloid Leukemia, to the USFDA.
February 12, 2018
Audent Therapeutics starts dosing patients for rare pediatric disease Crigler-Najjar Syndrome, as it tests recently fast tracked AT342
Audentes Therapeutics has started with dosing of patients in a Phase 1/2 clinical trial of its product candidate AT342 for…
February 12, 2018
Santen’s has potential treatment for patients with wet AMD
Santen’s topline results from the Phase I/II study of DE-122 for refractory wet age-related macular degeneration (AMD) suggest bioactivity of DE-122…
February 12, 2018
Bardoxolone methyl improves kidney functions for pulmonary arterial hypertension patients, Reata study suggests
Reata Pharmaceuticals has reported that its study that shows bardoxolone methyl can improve kidney functions for patients with pulmonary arterial…
February 12, 2018
ImmunoMet appoints two new executives
ImmunoMet Therapeutics, a private US-based biotechnology company, on Monday appointed two new executives, for medical and financial departments.
February 12, 2018
New technique for downstream bioconjugation process from ADC Biotechnology
ADC Biotechnology is making a new method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and…
February 9, 2018
Xeris Pharmaceuticals gets new ODD from the USFDA
Xeris Pharmaceuticals got its third orphane drug designation from the USFDA, this time for its treatment of Hyperinsulinemic Hypoglycemia.
February 9, 2018
BioPorto nets deal with Roche for distribution of test on Roche’s cobas analysers
BioPorto and Roche agreed that BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c…
February 9, 2018
Aquinox Pharmaceuticals enrolls the patients for testing ist lead drug candidate for bladder pain syndrome, results in Q3
Aquinox Pharmaceuticals has completed the list of candidates to be included in the clinical trial of its bladder pain syndrome…